NYSE International 100
10.642,80
PKT
+48,69
PKT
+0,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 12.02.21 | ING Group overweight | JP Morgan Chase & Co. | |
| 12.02.21 | ING Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.02.21 | ING Group buy | Jefferies & Company Inc. | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.02.21 | Siemens Outperform | Credit Suisse Group | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 12.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 12.02.21 | AXA buy | Jefferies & Company Inc. | |
| 12.02.21 | Allianz Hold | Jefferies & Company Inc. | |
| 12.02.21 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 12.02.21 | Santander Outperform | RBC Capital Markets | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 11.02.21 | TotalEnergies Neutral | UBS AG | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 11.02.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 11.02.21 | AstraZeneca Neutral | UBS AG | |
| 11.02.21 | Nokia Neutral | Credit Suisse Group | |
| 11.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.02.21 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.02.21 | Deutsche Telekom buy | UBS AG | |
| 11.02.21 | Prudential overweight | Barclays Capital | |
| 11.02.21 | AXA overweight | JP Morgan Chase & Co. | |
| 10.02.21 | AXA Outperform | RBC Capital Markets | |
| 10.02.21 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 10.02.21 | TotalEnergies Neutral | Credit Suisse Group | |
| 10.02.21 | TotalEnergies Outperform | RBC Capital Markets | |
| 10.02.21 | Sanofi buy | UBS AG | |
| 10.02.21 | Sanofi Sell | Deutsche Bank AG | |
| 10.02.21 | GSK Sell | Deutsche Bank AG | |
| 10.02.21 | TotalEnergies Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 10.02.21 | Novartis buy | Deutsche Bank AG | |
| 10.02.21 | Siemens overweight | JP Morgan Chase & Co. | |
| 10.02.21 | TotalEnergies overweight | Barclays Capital |